Prevention of<unk>  relies strongly on measures to reduce the spread of the viruses that cause respiratory infections (that is, handwashing, and avoiding exposure to those symptomatic with respiratory infections). Guidelines are mixed on the use of gloves, aprons, or personal protective equipment. In addition to good hygiene, an improved immune system is a great tool for prevention. One way to improve the immune system is to feed the infant with breast milk, especially during the first month of life. Respiratory infections were shown to be significantly less common among breastfed infants and fully breastfed RSV-positive hospitalized infants had shorter hospital stays than non or partially breastfed infants. Guidelines recommend exclusive breastfeeding for infants for the first 6 months of life. Palivizumab, a monoclonal antibody against RSV, can be administered to prevent<unk>  to infants less than one year of age that were born very prematurely or that have underlying heart disease or chronic lung disease of prematurity. Passive immunization therapy requires monthly injections during winter. Otherwise healthy premature infants that were born after a gestational age of 29 weeks should not be administered palivizumab as the harms outweigh the benefits. Passive protection through the administration of other novel monoclonal antibodies is also under evaluation. Immunizations for RSV are being developed but none are available currently outside of clinical trials. Tobacco smoke exposure has been shown to increase both the rates of lower respiratory disease in infants, as well as the risk and severity of<unk> . Tobacco smoke lingers in the environment for prolonged periods and on clothing even when smoking outside the home. Guidelines recommend that parents be fully educated on the risks of tobacco smoke exposure on children with<unk> .
Bronchiolitis
Heart failure
Bronchitis
Asthma
Bronchitis kettle
Pneumonia
Croup
Cystic fibrosis